|
2025
|
G/S
|
Pharmaceutical preparations |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of immunemediated, autoimmune, infla... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of multiple sclerosis |
|
|
G/S
|
Pharmaceutical preparations for the treatment of multiple sclerosis |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of multiple sclerosis |
|
|
G/S
|
Pharmaceutical preparations. |
|
2024
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of immunological, inflammatory, resp... |
|
|
Invention
|
Methods of making tolebrutinib.
Disclosed herein are improved synthetic routes for making (R)-1-... |
|
|
Invention
|
Treatment of moderate-to-severe asthma by administering rilzabrutinib. Methods for treating patie... |
|
|
Invention
|
Tyrosine kinase inhibitors.
The present disclosure provides compounds that are tyrosine kinase i... |
|
|
Invention
|
Rilzabrutinib for use in the treatment of itch associated with atopic dermatitis and/or prurigo n... |
|
|
Invention
|
Treatment of chronic spontaneous urticaria by administering (r)-2-[3-[4-amino-3-(2-fluoro-4-pheno... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of inflammatory, autoimmune, immune-... |
|
|
Invention
|
Topical pharmaceutical compositions comprising 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1h-pyr... |
|
|
Invention
|
Process of making 2-[(3r)-2-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]p... |
|
|
Invention
|
Process of making 2-[(3r)-2-[4-amino-3-(2-fluoro-4-phenoxy- phenyl)pyrazolo[3,4-d]pyrimidin-l-yl]... |
|
|
Invention
|
Methods for treating persistent or chronic immune thrombocytopenia in children, adolescents and a... |
|
|
Invention
|
Crystalline form of tolebrutinib and preparation method thereof.
Disclosed is a crystalline form... |
|
|
Invention
|
Process for preparing an fgfr inhibitor.
Disclosed herein are processes for preparing 8-(3-(4-ac... |
|
|
Invention
|
Therapeutic tyrosine kinase inhibitors for relapsing multiple sclerosis (rms).
This disclosure r... |
|
|
Invention
|
Methods of diagnosing and treating multiple sclerosis by detecting a biomarker in the cerebrospin... |
|
2023
|
G/S
|
Pharmaceutical preparations for the treatment of immune-mediated diseases and disorders. |
|
|
G/S
|
Development of pharmaceutical preparations and medicines; pharmaceutical research and development. |
|
|
Invention
|
Drug formulations of (r)-1-(1-acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1h-imidazo[4,5-... |
|
|
Invention
|
Drug formulations of (r)-1-(1-acryloylpiperidin-3-yl)-4-amino-3-(4- phenoxyphenyl)-1h-imidazo[4,5... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of multiple sclerosis. |
|
|
Invention
|
Methods for treating immune thrombocytopenia in subjects with cognitive impairment by administeri... |
|
|
Invention
|
Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl) pyrazolo[3,4-d] pyri... |
|
|
Invention
|
Methods for treating immune thrombocytopenia by administering (r)-2-[3-[4-amino-3-(2-fluoro-4-phe... |
|
|
Invention
|
Immunoproteasome inhibitors. Provided herein are compounds, such as a compound of Formula (I), or... |
|
|
Invention
|
Crystalline forms 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1h-pyrazolo[3,4-d]pyrimidin-1- yl]p... |
|
|
Invention
|
Therapeutic tyrosine kinase inhibitors for multiple sclerosis.
This disclosure relates to the f... |
|
|
Invention
|
Pyrazolopyrimidine compounds as kinase inhibitors.
The present disclosure provides compounds and... |
|
|
Invention
|
Therapeutic tyrosine kinase inhibitors for multiple sclerosis and myasthenia gravis |
|
|
Invention
|
Cyclic boronic esters and their uses. The present disclosure relates to cyclic boronic esters and... |
|
|
Invention
|
Methods of making modified btk inhibitors |
|
|
Invention
|
Methods of making tolebrutinib |
|
|
Invention
|
Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1- yl]pi... |
|
|
Invention
|
Solid forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl] piperidi... |
|
|
Invention
|
Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl]... |
|
2022
|
Invention
|
Crystalline forms of (r)-1-(1-acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1h-imidazo[4,5-... |
|
|
Invention
|
Crystalline form of tolebrutinib. The present disclosure relates to a novel crystalline form of T... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of multiple sclerosis excluding products for the re... |
|
|
Invention
|
Crystal form of tolebrutinib, preparation method therefor and use thereof.
The present invention... |
|
|
Invention
|
Salts and solid form of a btk inhibitor.
Disclosed herein are processes for preparing 2-[(3R)-3-... |
|
|
Invention
|
Methods for treating drug and vaccine induced immune thrombocytopenia by administering specific c... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of immunemediated, autoimmune, infla... |
|
2021
|
Invention
|
4-amino-3-(4-phenoxyphenyl)-1,3-dihydro-2h-imidazo[4,5-c]pyridin-2-one derivatives and salts ther... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders... |
|
|
Invention
|
Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors.
The present disclosure provides com... |
|
|
Invention
|
Quinolone derivatives as fibroblast growth factor inhibitors.
Compounds that are Fibroblast Grow... |
|
|
Invention
|
Treatment of acute respiratory distress syndrome and other disorders involving cytokine storm usi... |
